Fundz

Bitterroot Bio Launches Out Of Stealth With $145 Million Series A Financing To Develop Transformative Medicines In Cardio-Immunology

PRIVATEJun 07, 2023

Amount Raised

$145 Million

Round Type

Series A

Palo AltoBiotechnologyHealth Care

Investors

Koch Disruptive Technologies

Description

Bitterroot Bio, a biotechnology company focused on developing novel immunotherapies in cardiovascular disease, announced today a $145 million Series A financing round co-led by ARCH Venture Partners and Deerfield Management with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others.

Quick answer

Bitterroot Bio raised $145 Million in a Series A round, dated June 7, 2023. Investors: Koch Disruptive Technologies. Bitterroot Bio is based in Palo Alto, California, United States.

How much did Bitterroot Bio raise?
Bitterroot Bio raised $145 Million in a Series A round on June 7, 2023.
Who invested in Bitterroot Bio?
Koch Disruptive Technologies is named as investors in this round.
What does Bitterroot Bio do?
Harnessing the power of immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease
Where is Bitterroot Bio based and how big is it?
Bitterroot Bio is based in Palo Alto, California, United States.
Who are the decision-makers at Bitterroot Bio?
Fundz holds 1 contact at Bitterroot Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Bitterroot Bio that raised within 45 days of this round, from Fundz verified event records.

  • RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
  • Hubly raised $3M (Seed) on July 21, 2023.
  • Streamex Corp. raised $495K (Seed) on July 19, 2023.
  • SURGE Therapeutics raised $32M (Series B) on July 19, 2023.
  • KayoThera, Inc. raised an undisclosed amount (Series A) on July 19, 2023.
  • ALZpath raised an undisclosed amount (Funding Round) on July 18, 2023.

Who to call at Bitterroot Bio, and when

A new round usually means Bitterroot Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bitterroot Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bitterroot Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bitterroot Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bitterroot Bio

Location

Palo Alto, California, United States

About

Harnessing the power of immunotherapy to develop and deliver transformative medicines for patients with cardiovascular disease

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bitterroot Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Bitterroot Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Bitterroot Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.